Research and Methods Core
研究和方法核心
基本信息
- 批准号:10663332
- 负责人:
- 金额:$ 39.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-01 至 2027-07-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdvanced Malignant NeoplasmAmericanCaringCommunicationCommunication MethodsContinuity of Patient CareDevelopmentDisparityDissemination and ImplementationEffectivenessElementsEnsureEquityEvaluationFutureGoalsHealthHealthcare SystemsIndividualInequityInformation DisseminationInterventionInvestigationKnowledgeMalignant neoplasm of lungMeasuresMethodologyMethodsModelingMonitorNamesNursesOutcomePatient CarePatientsPennsylvaniaPilot ProjectsProcessRecommendationResearchResearch MethodologyResearch PersonnelScienceSequential Multiple Assignment Randomized TrialShapesStatistical MethodsTelemedicineTestingUniversitiesVisitbehavioral economicscancer carecancer riskcare deliveryclinical careclinical practicecompare effectivenessdesigndigitalevidence basehealth care deliveryhealth equityimplementation frameworkimprovedinnovationinsightlung cancer screeningpatient orientedpragmatic trialprogramsscreeningshared decision makingsuccesssuccessful interventiontelehealthtelehealthcaretherapy designtooltrial design
项目摘要
PROJECT SUMMARY/ABSTRACT (RESEARCH AND METHODS CORE)
The objective of the Research and Methods Core of the University of Pennsylvania Telehealth Research
Center in Cancer Care (Penn TRC) is to advance the research program of the Center through the design and
testing of innovative telehealth strategies to improve effectiveness and equity across the cancer care
continuum. The Research and Methods Core will develop new methodological approaches using insights from
communication science and behavioral economics and employ innovative mixed methods and rapid-cycle
approaches to advance the evidence base for optimal telehealth care delivery. The Research and Methods
Core will address three major questions: 1) How can we employ insights from communication science and
behavioral economics to effectively integrate high-quality telehealth into cancer care delivery?; 2) How can we
understand mechanisms of successful telehealth care delivery using multilevel, mixed methods approaches to
allow for refinement and more precise application of successful interventions in future projects within and
beyond our health care system?; and 3) How can we integrate health equity into our Center’s research, with
respect to frameworks, intervention design, monitoring, methods, and measures, to ensure that telehealth
reduces, rather than exacerbates, persistent health and digital inequities? The specific aims of the Research
and Methods Core are to: 1) Apply insights and innovations from communication science, behavioral
economics, rapid-cycle approaches, and statistical methods to design and test synchronous telehealth
strategies, supported by asynchronous elements, to improve the effectiveness and equity of cancer care; 2)
Employ advanced mixed methods approaches to elucidate the multilevel individual and contextual
mechanisms that contribute to the effectiveness of telehealth strategies; 3) Design, conduct, and evaluate
findings from a pragmatic trial and two pilot projects to compare the effectiveness of synchronous telehealth
strategies to improve lung cancer care; and 4) Support widespread communication and dissemination of
results to diverse stakeholders to advance integration of optimal telehealth care delivery nationally and to
evaluate comprehensively the Center’s research progress and success of dissemination and implementation
activities. Achieving the Research and Methods Core aims will be central to ensuring the Penn TRC achieves
its goal of producing new fundamental knowledge on telehealth with the potential to transform cancer care
delivery, equity, and outcomes for millions of Americans.
项目摘要/摘要(研究方法核心)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Katharine A. Rendle其他文献
Patient Perspectives on Primary HPV Testing for Routine Cervical Cancer Screening
- DOI:
10.1007/s11606-019-05175-4 - 发表时间:
2019-07-16 - 期刊:
- 影响因子:4.200
- 作者:
Shannon N. Ogden;Karen Glanz;Marilyn M. Schapira;Claire Bocage;Whitney Eriksen;Katharine A. Rendle - 通讯作者:
Katharine A. Rendle
Perceptions, facilitators, and barriers of participation for a behavioral weight loss group-based telehealth program for breast cancer survivors: a qualitative study
- DOI:
10.1007/s00520-024-08999-x - 发表时间:
2024-11-20 - 期刊:
- 影响因子:3.000
- 作者:
Yangzi Liu;Elizabeth De Jesus;Macy Goldbach;Robert S. Krouse;Carmen E. Guerra;Katharine A. Rendle;Tamara J. Cadet;Kelly C. Allison;Julia Tchou - 通讯作者:
Julia Tchou
Lay Beliefs About the Accuracy and Value of Cancer Screening.
人们对癌症筛查的准确性和价值的看法。
- DOI:
- 发表时间:
2018 - 期刊:
- 影响因子:5.5
- 作者:
Megan C. Roberts;R. Ferrer;Katharine A. Rendle;S. Kobrin;S. Taplin;B. Hesse;W. Klein - 通讯作者:
W. Klein
Novel CRTH2 receptor antagonists
新型 CRTH2 受体拮抗剂
- DOI:
- 发表时间:
2005 - 期刊:
- 影响因子:0
- 作者:
K. Chaiyachati;R. Beidas;M. Lane;Katharine A. Rendle;R. Shelton;Elinore J. Kaufman - 通讯作者:
Elinore J. Kaufman
99 - Potentially Modifiable Factors in the Screening Process to Prevent Death from Colorectal Cancer
- DOI:
10.1016/s0016-5085(18)30575-4 - 发表时间:
2018-05-01 - 期刊:
- 影响因子:
- 作者:
Chyke A. Doubeni;Stacey A. Fedewa;Theodore R. Levin;Alexis M. Zebrowski;Christopher Jensen;Virginia P. Quinn;Wei K. Zhao;Rebecca S. Pepe;Katharine A. Rendle;Ann G. Zauber;Tracy A. Becerra-Culqui;Shivan J. Mehta;Robert Fletcher;Joanne E. Schottinger;Douglas A. Corley - 通讯作者:
Douglas A. Corley
Katharine A. Rendle的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Katharine A. Rendle', 18)}}的其他基金
De-Implementation of Low-Value Cervical Cancer Screening
低价值宫颈癌筛查的取消
- 批准号:
10675074 - 财政年份:2022
- 资助金额:
$ 39.55万 - 项目类别:
De-Implementation of Low-Value Cervical Cancer Screening
低价值宫颈癌筛查的取消
- 批准号:
10523218 - 财政年份:2022
- 资助金额:
$ 39.55万 - 项目类别:














{{item.name}}会员




